CRPFY yields 5.36% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, CRPFY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRPFY + JNJ for your $10,000?
Corporación Financiera Colombiana S.A. operates as a private financial institution in Columbia and Central America. It operates through Financial, Power and Gas, Infrastructure, Hospitality, Agroindustry, and Others segments. The company provides investment banking services, including merger and acquisition advisory services; capital market services, comprising issuance and placement of securities, such as bonds, securitizations, shares, commercial papers, bonds convertible into shares, etc.; and fundraising services. It also offers treasury products, consisting of legal tender, foreign currency, and investment and money market products; and commercial banking services. It also operates road concessions and hotels; produces and commercializes palm oil, palm kernel oil, palm kernel cake, technically specified rubber, certified rice seed, and bio-inputs; and manufactures synthetic fabrics, products specialized in providing shadow, and enclosure solutions under the Polisombra brand, as well as bonding and fastening media for agro-industrial and home use. In addition, the company operates 3,204 kms of gas pipeline; and distributes natural gas to approximately 3.72 million users. The company was founded in 1961 and is based in Bogotá, Colombia.
Full CRPFY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.